IP Library Granted Patent US 10,743,604
Granted Patent B2
US 10,743,604 · App. 15/825,232 · Granted Aug 18, 2020

Articles of manufacture releasing an active ingredient

Inventors: Karine Theberge (La Prairie, CA); Isabelle Goudreault (Montreal, CA); Francois Quirion (Montreal, CA); Gerald Perron (Boucherville, CA)
Assignee: NNTT Tech Inc.
A43B1/0045A43B17/003A61K8/0208A61K8/0241A61K8/553A61L15/42A61L15/44A61Q19/00D06M23/08D06M23/12A61K9/0014A61K9/1617A61K9/70A61K2800/56A61L2300/602A61L2300/622A61L2300/802A61M35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,743,604
App. No.
15/825,232
Granted
Aug 18, 2020
Kind
B2
Abstract

The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates to methods for manufacturing these articles of manufacture, to vehicles for applying the formulation to these articles of manufacture, and to perception indicators indicating the presence and the amount of formulation comprising an active agent applied to an article of manufacture.

Claims (11)

1. A formulation for applying an active agent to a living subject, the formulation comprising a plurality of hydrophobic microparticles, the hydrophobic microparticles having electrostatically uncharged outer surfaces, and the hydrophobic microparticles and the electrostatically uncharged outer surfaces of the hydrophobic microparticles including a non-crosslinked carrier material throughout which is dispersed the active ingredient, wherein the non-crosslinked carrier material includes one or more of a lipid, a fatty acid, a phospholipid, a wax, a sterol, and a glyceride, wherein an activity, temperature, pH, or any combination thereof of the living subject triggers progressive erosion of the electrostatically uncharged outer surfaces of the hydrophobic microparticles so as to release the non-crosslinked carrier material and the active ingredient for transfer to the living subject, and wherein when the formulation is applied to an article, the article is configured to place the electrostatically uncharged outer surfaces of the hydrophobic microparticles into contact with the living subject.

2. A formulation as defined in claim 1 , wherein the carrier material is caproic acid, caprylic acid, capric acid, undecanoic acid, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, heptadecanoic acid, stearic acid, oleic acid, elaidic acid, linoleic acid, linolenic acid, arachidic acid, arachidonic acid, tripalmitin, tristearin or glycerol monostearate or any combination thereof.

3. A formulation as defined in claim 1 , wherein the active ingredient is a cosmetic agent, a therapeutic agent, a pharmaceutical agent, a nutraceutical agent, a cleansing agent, a detoxifying agent or a fragrance or any combination thereof.

4. A formulation as defined in claim 1 , wherein the carrier material includes a natural butter.

5. A formulation as defined in claim 4 , wherein the natural butter is olive butter, mango butter, grape seed butter, shea butter or lemon butter or any combination thereof.

6. A formulation as defined in claim 1 , wherein the formulation further comprises a binding agent.

7. A formulation as defined in claim 1 , wherein the binding agent is a polyacrylic (PAC), a polyurethane (PU), a polysiloxane (POL), a polyvinylpyrrolidone (PVP), a guar gum or an acrylic base or any combination thereof.

8. A formulation as defined in claim 1 , wherein one or more of the microparticles have a size in the range from about 0.1 μm and about 20 μm.

9. A formulation as defined in claim 1 , wherein one or more of the microparticle have a size in the range of about 2 μm and about 20 μm.

10. A formulation as defined in claim 1 , wherein the microparticles have a melting temperature between about 20° C. and about 60° C.

11. A formulation as defined in claim 1 , further comprising a surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2020
From: BIOMOD CONCEPTS INC.
To: NNTT TECH INC.
Reel/Frame 052921/0698 →
Continuity (4)
Continuation 12680836 · Mar 30, 2010
Continuation PCTCA2009001012 · Jul 17, 2009
Provisional Application 61081911 · Jul 18, 2008
Related Publication 20180146735A1 · May 31, 2018